In 2019 GGD Amsterdam launched a new study involving 500 families in Amsterdam: AIMS. AIMS stands for ‘Amsterdam Infant Microbiome Study’. The aim of this study is to examine how microorganisms such as bacteria and viruses develop on and within the bodies of young children. The microbiome is the collective name for all these microorganisms. We also aim to study the influence of the microbiome on the onset of diseases of affluence (also known as “Western diseases”) such as diabetes, obesity, cardiovascular diseases and oral health problems.
Discover more with AIMS
Working with Amsterdam families, we want to obtain a clearer picture of the health of Amsterdam children right from the start of their lives. This will enable us to provide them with even better care: Amsterdam’s children of today will be helping its children of tomorrow. Once we have obtained concrete research results, we will publish them for you on this website.
AIMS is a pioneering study
AIMS is the world’s first-ever study to chart microbiome development among such a large group of young children, over a three-year period. We are aiming to get 500 AIMS children and their families involved in this study. The whole family can participate in AIMS. The involvement of various family members will also enable us to study the influence of family members on the development of the youngest child’s microbiome.